TransPharma

Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance

... associated with the in-licensing transaction with transpharma Medical and a charge of $88.9 million for restruct...associated with in-licensing transaction with transpharma (2008) - .0...with in-licensing transactions with BioMS and transpharma (2008) - .07 Bene...

Lilly Reports Strong First-Quarter 2009 Results

...ocess research and development charges associated with SGX acquisition and in-licensing transactions with BioMS and transpharma - .10 Benefit from resolution of IRS audit - (.19) ...

Lilly Reports Fourth-Quarter and Full-Year 2008 Results

...cquisitions (2007) and in-licensing transactions with BioMS and transpharma (2008) and OSI, MacroGenics and Glenmark (2007) ...th SGX acquisition and in-licensing transactions with BioMS and transpharma - .10 Benefit from resolution of IRS ...

TransPharma in Medical Technology

Lilly and TransPharma Medical Announce Licensing and Development Agreement

Lilly Gains Access to Transdermal PTH Program for Osteoporosis INDIANAPOLIS, Ind. and LOD, Israel, June 12 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY ) and TransPharma Medical Ltd. today announced that the two companies have entered into a licensing and development agreem...

TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment

... LOD, Israel--(BUSINESS WIRE)--Jul 9, 2007 - transpharma Medical Ltd., a specialty pharmaceutical company f...asing compliance," said Dr. Daphna Heffetz, CEO of transpharma Medical Ltd. "Strongly encouraged by the results o...ic small molecules, peptides and proteins. About transpharma Medical Established in 2000,...

TransPharma in Biological Technology

Lilly Highlights Transformation Strategy for Wall Street, Reviews Robust Pipeline and Sets 2009 Financial Guidance

... acquisitions (2007) and in-licensing transactions with BioMS and transpharma (2008) and OSI, MacroGenics and Glenmark (2007) .10 ...with SGX acquisition and in-licensing transactions with BioMS and transpharma - .10 Benefit from resolution of IR...

Lilly Reports Solid Second-Quarter Results

...ties, resulting in both the in-licensing deal with transpharma and the announced acquisition of SGX Pharmaceutica...associated with the in- licensing transaction with transpharma Medical. In the second quarter of 2007, the compan...ges associated with the licensing arrangement with transpharma Medical Ltd. of $35.0 million, which decreased ear...